Organometallics
Article
The powder was triturated 3 times with 1 mL diethyl ether to yield
the title compound as a light yellow solid. Crystals suitable for X-ray
crystallography were grown by vapor diffusion using THF/Pentane.
Yield = 136.6 mg (57%). 1H NMR (500 MHz, benzene-d6) δ 8.44 (q,
J = 6.9 Hz, 1H), 7.21−7.07 (m, 5H), 6.36 (d, J = 8.2 Hz, 2H), 3.29 (s,
6H), 1.52 (t, J = 3.6 Hz, 6H). 31P {1H} NMR (202 MHz, benzene-d6)
δ −4.11. 13C NMR (126 MHz, benzene-d6) δ 158.69, 139.06, 135.47
(t, J = 8.2 Hz), 133.93, 132.87 (t, J = 3.5 Hz), 129.81 (d, J = 34.7 Hz),
127.01 (d, J = 5.7 Hz), 119.28, 103.83, 100.37, 55.07, 13.27 (t, J =
15.4 Hz). (Note that in CDCl3 this compound is in equilibrium with a
dimer, resulting in two peaks at −3.2 and 9.50 ppm.)
Synthesis of Chloro(2-dimethylphosphino-2′,6′-dimethoxy-
1,1′-biphenyl)(2′-amino-1,1′-biphenyl-2-yl)palladium(II) (5).
In a nitrogen filled glovebox, a 20 mL scintillation vial was charged
with (2′-methylamino-1,1′-biphenyl-2-yl)methanesulfonatopalladium-
(II) dimer (559.6 mg, 0.7291 mmol) and MeSPhos (4) (400 mg,
1.458 mmol). Dry, degassed dichloromethane (17 mL) was added
with a Teflon coated stir bar. The black solution was allowed to stir
under nitrogen for 1.5 h. The solvent was then removed with the use
of a rotary evaporator, cold pentane was added, and the
heterogeneous mixture filtered using a glass frit. The solids were
washed sequentially with 10 mL diethyl ether, then methyl tert-butyl
ether. The purified precatalyst was collected by washing the frit with
100 mL dichloromethane and removing the solvent under high
vacuum. Crystals suitable for X-ray crystallography were grown by
vapor diffusion using CDCl3/diethyl ether. 1H NMR (500 MHz,
CDCl3) δ 8.02 (dd, J = 13.2, 7.8 Hz, 1H), 7.55 (t, J = 7.6 Hz, 1H),
7.52−7.42 (m, 2H), 7.37 (t, J = 8.4 Hz, 1H), 7.31 (d, J = 6.8 Hz, 1H),
7.22−7.17 (m, 1H), 7.11 (s, 0H), 7.04 (s, 1H), 6.77 (s, 1H), 6.65 (t, J
= 9.2 Hz, 2H), 3.72 (s, 6H), 1.32 (d, J = 11.1 Hz, 3H), 1.05 (d, J = 9.8
Hz, 3H). 31P {1H} NMR (202 MHz, CDCl3) δ 8.17. 13C NMR (151
MHz, methylene chloride-d2) δ 158.54, 158.19, 145.29 (d, J = 4.4
Hz), 142.85 (d, J = 3.3 Hz), 141.60, 140.01 (d, J = 6.8 Hz), 138.74,
137.54 (d, J = 13.6 Hz), 134.87 (d, J = 15.5 Hz), 133.34 (d, J = 7.3
Hz), 132.22, 131.92, 131.04 (d, J = 2.7 Hz), 130.48, 129.26, 128.53,
127.75 (d, J = 11.4 Hz), 127.39 (d, J = 4.7 Hz), 127.03 (d, J = 9.4
Hz), 125.74, 122.61 (d, J = 2.7 Hz), 118.21 (d, J = 4.0 Hz), 104.36 (d,
J = 26.5 Hz), 67.59, 55.98 (d, J = 20.3 Hz), 40.35 (d, J = 2.5 Hz),
39.94, 15.29 (d, J = 34.5 Hz), 13.89 (d, J = 29.8 Hz).
General Procedure for MeSPhos-Catalyzed Aminations. In a
nitrogen filled glovebox, an unregulated pressure vessel was charged
with the appropriate aryl chloride (1 equiv, 1 mmol), dioxane (4 mL),
the appropriate amine (1.2 mmol), and sodium tert-pentoxide (1.4
mmol). The precatalyst (0.04 mmol, 4% loading) was added as a
stock solution in dioxane. A Teflon coated stir bar was added, and the
vessel sealed and removed from the glovebox. The vessel was heated
to 90 °C in an oil bath behind a blast resistant shield for 20 h with
strong stirring, during which time an extremely dark red color
developed. The vessel was removed from the oil, diluted with diethyl
ether, and filtered through a pad of Celite. Reaction outcome was
determined by comparison of the proton NMR spectrum to
previously published results. Crude reactions were further analyzed
by GC-MS and 15N/1H HMBC. Yields are estimated based on
recovered mass and corrected for purity as determined by GCMS/1H
NMR.
standard, tetraethyl-1,2-ethanebisphosphonate in C6D6 was added.
Palladium(dba)2 (7.2 mg, 12.5 μmol) was added as a solution in
dioxane (400 μL). The tube was then quickly removed from the
glovebox and inserted into the instrument.
Stoichiometric Cross-Coupling of Griseofulvin and 3-
Fluoro-N-methylaniline. In a nitrogen filled glovebox a 1 dram
vial was charged with MeSPhos Pd G4 precatalyst 5 (21 mg, 31.86
μmmol), griseofulvin (9.5 mg, 26.9 μmol), and 600 μL of d8-
tetrahydrofuran. Sodium tert-pentoxide (4.9 mg, 41 μmol) was added
resulting in an immediate change to a copper color. The reaction
mixture was taken up into a syringe and filtered with a 0.2 μm syringe
filter directly into a J-Young adapted NMR tube. The tube was sealed
and removed from the glovebox and an NMR spectrum collected. The
reaction was returned to the glovebox and 3-fluoro n-methylaniline
(7.5 mg, 69.99 μmol) was added by syringe. An additional amount
(1.8 mg, 16.34 μmol) of sodium tert-pentoxide was added and the
reaction sealed and removed from the glovebox. Addition of the
amine resulted in an immediate color change to black along with
precipitation of a black solid. An NMR spectrum was subsequently
obtained.
Kinetics of Cross-Coupling Reaction. In a nitrogen filled
glovebox, a 20 mL scintillation vial was charged with a Teflon coated
stir bar and charged with p-chlorobenzonitrile (137.57 mg, 1.0 mmol),
hexamethylbenzene internal standard (28 mg, 0.17 mmol), N-
methylaniline (129 μL 1.2 mmol), and the appropriate precatalyst
(0.022 mmol). Dioxane (2 mL) was then added. A solution of sodium
tert-pentoxide (154.2 mg, 1.4 mmol) was prepared in 2.0 mL dioxane.
The reaction mixture was heated to 90 °C in an oil bath, and the
sodium tert-pentoxide added by syringe. Aliquots (400 μL) were
taken by syringe and quenched by addition to 2 mL methanol. The
solvent was then removed under reduced pressure with gentle heating
and dried on high vacuum. (Note: the starting material may be volatile
depending on pressure and temperature, and so integrals of starting
material may be inaccurate if a consistent solvent removal protocol is not
followed. The product is not volatile and not subject to the same
variability.) The time in all experiments is the time when the base was
1
added. See SI for details on quantitative H NMR.
X-ray Crystallography. Diffraction intensities for precatalyst 5
and PdCl2(MeSPhos)2 were collected at 173 K, respectively, on a
Bruker Apex2 CCD diffractometer using Cu Kα radiation, λ =
1.54178 Å. Space groups were determined based on systematic
absences (PdCl2(MeSPhos)2) and intensity statistics (5). Absorption
corrections were applied by SADABS.45 Structures were solved by
direct methods and Fourier techniques and refined on F2 using full
matrix least-squares procedures. All non-H atoms were refined with
anisotropic thermal parameters. H atoms in all structures were refined
in calculated positions in a rigid group model. Solvent molecules Et2O
in precatalyst 5 fill out empty space around an inversion center and
are highly disordered. This solvent molecule was treated by
SQUEEZE;46 corrections of the X-ray data by SQUEEZE is 28
electron/cell. The crystal structure of PdCl2(MeSPhos)2 seems to
have orthorhombic pseudosymmetry based on symmetry of the
central heavy atoms fragment, but the structure was solved and
refined in a monoclinic crystallographic system. All calculations were
performed by the Bruker SHELXL-2014 package.47
The X-ray crystallographic data for molecule
5 and
In Situ Formation of Oxidative Addition Complexes for
Kinetic Analysis. To a J-Young adapted NMR tube in a nitrogen
filled glovebox was added the appropriate phosphine (2.0 equiv, 25
μmol). The aryl chloride, p-chloroanisole (32 μL, 250 μmol), was
added by syringe. Dioxane (68 μL) was added by syringe. A sealed
capillary tube containing the internal standard, tetraethyl-1,2-
ethanebisphosphonate in C6D6 was added. Palladium(dba)2 (7.2
mg, 12.5 μmol) was added as a solution in dioxane (400 μL). The
tube was then quickly removed from the glovebox and inserted into
the instrument. The time in all experiments is the time from
palladium addition. See SI for details on quantitative 31P NMR.
In Situ Formation of Active Catalysts Using Pd(dba)2. To a J-
Young adapted NMR tube in a nitrogen filled glovebox was added the
appropriate phosphine (2.0 equiv, 0.25 μmol). Dioxane (68 μL) was
added by syringe. A sealed capillary tube containing the internal
PdCl2(MeSPhos)2 have been deposited at the Cambridge Crystallo-
graphic Data Centre (CCDC) under deposition numbers CCDC
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge on the
■
S
Additional discussion of general considerations, addi-
tional syntheses, and commentary on procedures,
J
Organometallics XXXX, XXX, XXX−XXX